Related Experiment Videos
[Moraxella catarrhalis in chronic and relapsing respiratory tract infections in children]
Abstract:
Examination of 700 children with chronic and relapsing respiratory tract infections showed that during the period from 1996 to 2003 Moraxella catarrhalis strains were isolated from the sputum of 5.5-9.7% of the patients. The frequency of the emergence was the third after Haemophilus influenzae and Streptococcus pneumoniae. In healthy children M. catarrhalis was isolated in 2.7% of the cases. The most frequent detection of M. catarrhalis was stated in children under 1 year (4.5%). The antibiotic susceptibility tests revealed that the majority of the M. catarrhalis isolates had beta-lactamase activity, were resistant to benzylpenicillin, ampicillin and lincomycin and highly susceptible to amoxycillin/clavulanate, macrolides, certain cephalosporins and levofloxacin. The isolates were most frequent in the patients of the rather severe contingent (congenital lung disease, alveolitis, chronic pneumonia, bronchial asthma). In such patients the bronchoobstructive syndrome was more frequent (46.6%). High frequency of the affection of the upper respiratory tracts in the examined children was stated (62.1%).
Insights
Moraxella catarrhalis is a common cause of respiratory infections in children, particularly those under one year old. Many strains exhibit antibiotic resistance, highlighting the need for effective treatment strategies.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Respiratory Medicine
Background:
- Chronic and relapsing respiratory tract infections are significant health concerns in children.
- Moraxella catarrhalis is an opportunistic pathogen increasingly recognized in pediatric respiratory infections.
Purpose of the Study:
- To investigate the prevalence and antibiotic susceptibility of Moraxella catarrhalis in children with respiratory infections.
- To identify risk factors and clinical associations of M. catarrhalis infections in pediatric patients.
Main Methods:
- Retrospective analysis of sputum samples from 700 children with respiratory infections (1996-2003).
- Bacteriological isolation and identification of Moraxella catarrhalis.
- Antibiotic susceptibility testing including beta-lactamase activity assessment.
Main Results:
- Moraxella catarrhalis was isolated from 5.5-9.7% of children with respiratory infections, ranking third in frequency after Haemophilus influenzae and Streptococcus pneumoniae.
- Prevalence was highest in children under 1 year (4.5%) and in those with severe underlying conditions like congenital lung disease and bronchial asthma.
- Most isolates demonstrated beta-lactamase activity, conferring resistance to benzylpenicillin, ampicillin, and lincomycin, but remained susceptible to amoxicillin/clavulanate, macrolides, cephalosporins, and levofloxacin.
Conclusions:
- Moraxella catarrhalis is a significant pathogen in pediatric respiratory infections, particularly in infants and children with severe lung conditions.
- Antibiotic resistance is prevalent, necessitating susceptibility-guided therapy, with amoxicillin/clavulanate and macrolides showing good efficacy.
Related Concept Videos
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Atypical Pneumonia
Respiratory Syncytial Virus Disease
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Asthma I: Introduction